·
3 MIN READ

AMA launches resource to help physicians meet DEA training requirement

The AMA Ed Hub™ has a new educational webpage for physicians to complete required training on treating patients with opioid or other substance use disorders.

Press Releases
Rahul Gupta, MD, speaking at the 2023 National Advocacy Conference
·
5 MIN READ

Every 5 minutes a person dies of drug overdose. This must end.

Rahul Gupta, MD, MPH, is the first physician to direct the White House’s drug-control policy. Learn why he says treatment is key to the strategy.

Overdose Epidemic
·
13 MIN READ

Feb. 24, 2023: National Advocacy Update

FDA advisory panels vote 19-0 in favor of OTC naloxone and more in the latest National Advocacy Update.

Advocacy Update
·
2 MIN READ

AMA: FDA panels’ naloxone recommendation will save lives

Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.

Press Releases
Profile of smiling person looking out the window
·
4 MIN READ

Meet 25 heroes saving lives amid the drug-overdose epidemic

It’s time to pursue policies shown to help. An AMA report celebrates the physicians and advocates working to follow the evidence.

Overdose Epidemic
·
8 MIN READ

Dec. 2, 2022: National Advocacy Update

Moving from policy to action: Fighting the nation’s drug overdose and death epidemic, and more in the latest National Advocacy Update.

Advocacy Update
·
14 MIN READ

Nov. 11, 2022: National Advocacy Update

Bipartisan House letter coincides with launch of APM coalition and more in the latest National Advocacy Update.

Advocacy Update
Narcan kit
·
3 MIN READ

FDA naloxone guidance helps harm-reduction groups’ work to save lives

Learn how new clarity from the FDA on burdensome requirements for bulk purchase of naloxone aid underserved communities.

Overdose Epidemic
·
7 MIN READ

Sept. 30, 2022: National Advocacy Update

Physicians’ unified message to Congress: Reform Medicare pay now in the latest National Advocacy Update.

Advocacy Update